PRESS RELEASE: NACON LAUNCHES RIGHTS ISSUE WITH PRE-EMPTIVE RIGHTS

Written by Customer Service on July 3, 2024. Posted in Public Companies.

NACON THIS PRESS RELEASE MUST NOT BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. THIS PRESS RELEASE IS FOR INFORMATION ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR AN INVITATION TO BUY SECURITIES IN ANY JURISDICTION. Press releaseLesquin, 3 July 2024, 8.00 am NACON LAUNCHES RIGHTS ISSUE WITH PRE-EMPTIVE RIGHTS OF APPROXIMATELY €16.50 MILLION, WHICH MAY BE INCREASED TO €19 MILLION IF THE EXTENSION OPTION IS EXERCISED IN FULL Main terms Issue with pre-emptive rights for shareholders Subscription price: €1.10 per share, representing a discount of 7.3% to the closing price on 1 July 2024 Subscription ratio: 47 pre-emptive rights give the right...

Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD

Written by Customer Service on July 3, 2024. Posted in Public Companies.

Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life Dupixent is the first new treatment approach for COPD in more than a decade and a new option for approximately 220,000 adults in the EU Approval represents the sixth approved indication for Dupixent in the EU and seventh approved indication globally Paris and Tarrytown, NY, July 3, 2024. The European Medicines Agency (EMA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised...

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

Written by Customer Service on July 3, 2024. Posted in Public Companies.

First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life Dupixent is the first new treatment approach for COPD in more than a decade and a new option for approximately 220,000 adults in the European Union (EU) Approval represents the sixth approved indication for Dupixent in the EU and seventh approved indication globally TARRYTOWN, N.Y. and PARIS, July 03, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has approved Dupixent® (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD)...

BlueRush Pleased to Report Q3 Results for Fiscal 2024 with Continued Focus on Development of Generative AI Capabilities, Cost Reduction and Optimization of Go-to-Market Activities

Written by Customer Service on July 3, 2024. Posted in Earnings Releases And Operating Results.

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) — BlueRush Inc. (“BlueRush” or the “Company“) ‎‎‎(TSXV:BTV; OTCQB:BTVRF), ‎a personalized video Software as a Service (“SaaS“) company, today announced its financial results for the three and nine months ended April 30, 2024. “The future of BlueRush is very much about AI, positioning us to open new market opportunities while accelerating growth and new logo acquisition,” said Steve Taylor, CEO of BlueRush. “IndiVideo’s® architecture is ideally suited to allow for AI-generated videos to be created quickly and economically and for these videos to be personalized at scale.” Strategic and financial highlights: BlueRush selected by one of the world’s largest asset managers to support communication to group retirement (401K) participants. Personalized AI-generated...

Lucas Dow appointed as Managing Director and Chief Executive Officer

Written by Customer Service on July 3, 2024. Posted in Public Companies.

MONTRÉAL, July 02, 2024 (GLOBE NEWSWIRE) — North American lithium producer Sayona Mining Limited (“Sayona”) (ASX:SYA; OTCQB:SYAXF) is pleased to announce that Mr. Lucas Dow has been appointed to the role of Managing Director and Chief Executive Officer (MD & CEO) effective 3 July 2024. Lucas first joined the Board as a Non-Executive Director on 14 February 2024 and will now assume the MD & CEO role with a hand over from Interim CEO, James Brown. It is expected James will remain as an Executive Director until 31 January 2025 to facilitate the hand over and business continuity after which he will return to a Non-Executive Director role. Lucas is a highly experienced mining executive with a proven track record of outstanding performance across a diverse range of businesses, commodities and geographies, skills which will...

Rapid7 Completes IRAP PROTECTED Assessment

Written by Customer Service on July 2, 2024. Posted in Public Companies.

Australian Government agencies can access the Rapid7 Insight Platform to keep pace with dynamic cloud environments and tackle an expanding attack surface MELBOURNE, Australia, July 02, 2024 (GLOBE NEWSWIRE) — Rapid7, a leader in extended risk and threat detection, has announced the successful completion of an Information Security Registered Assessors Program (IRAP) assessment to the PROTECTED Level for key solutions within the Rapid7 Insight Platform. The solutions assessed are: InsightIDR, InsightVM, InsightAppSec, and InsightConnect. This achievement enables Australian Government agencies requiring PROTECTED level controls to access Rapid7’s industry-leading, practitioner-first security solutions, which encompass vulnerability management, application security, orchestration and automation, and detection and response. Rob Dooley,...

NORBIT ASA – Mandatory notification of trades and disclosure of share lending

Written by Customer Service on July 2, 2024. Posted in Public Companies.

Trondheim, 3 July 2024: Reference is made to the stock exchange announcement by Norbit ASA (“NORBIT” or the “Company“) (Euronext Oslo Børs trading symbol: NORBT) of 2 July 2024 (the “Announcement“) regarding the successful private placement raising gross proceeds of approximately NOK 200 million (the “Private Placement“) at a price per share of NOK 77 (the “Offer Price“). All terms used in this notice shall have the meaning ascribed to such terms in the Announcement. Mandatory notification of trades The following primary insiders in the Company and close associates of primary insiders were allocated Offer Shares in the Private Placement at the Offer Price as follows: Reitan Kapital AS (“Reitan Kapital“), a company closely associated with the Company’s Board...

BetterLife Announces Closing of a Private Placement

Written by Customer Service on July 2, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announced that it has closed a non-brokered private placement, previously announced on June 13, 2024, pursuant to which the Company issued 1,750,000 units (“Units”) at a price of $0.10 per Unit for aggregate gross proceeds of $175,000 (the “Offering”). Each Unit is comprised of one common share and one full warrant. Each warrant entitles the holder thereof to acquire one common share at an exercise price of $0.13 at any time up to 24 months from the closing of the Offering. The Units sold pursuant to the Offering will be subject to a four month hold...

NORBIT ASA – Disclosure of shareholding

Written by Customer Service on July 2, 2024. Posted in Public Companies.

3 July 2024: Reference is made to the stock exchange announcement made on 2 July 2024 by Norbit ASA, regarding the completion of a private placement of 2,597,403 new shares. Upon registration of the share capital increase relating to the private placement with the Norwegian Registry of Business Enterprises (Nw. Foretaksregisteret), VHF Invest AS will on an entity basis be diluted to cross below the disclosure of holdings threshold of 10% as set out in the section 4-2 of the Norwegian Securities Trading Act. VHF Invest AS is controlled by Steffen Kirkenes. Following completion of the private placement and the registration of the share capital increase relating thereto, the aggregate holdings of Steffen Kirkenes, through VHF Invest AS (6,164,495 shares; 9.82%) and Draupnir Invest AS (3,602,949; 5.74%), will comprise of 9,767,444 shares,...

Canada Carbon Holds First Meeting of the Asbury Community Advisory Board

Written by Customer Service on July 2, 2024. Posted in Public Companies.

Notre-Dame-du-Laus, QC, Canada, July 02, 2024 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company” or “CCB”) (TSX-V: CCB), in partnership with the Municipality of Notre-Dame-du-Laus (“NDL“), is pleased to announce that the Community Advisory Board (“CAB“) has convened for its first work session. The announcement of the creation of the Community Advisory Board was made last December (see Press Release dated 12/14/2023. The objective is to establish a formal construct that guarantees information exchange, fosters collaboration and involvement from all stakeholders, and ensures a positive impact on the community while stimulating the regional economy. The CAB consists of members from various sectors, each bringing significant expertise to fully achieve the objective of this initiative. The CAB is tasked with...

Month: July 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice